arrow
L

Lawren VandeVrede

University of California San Francisco
H指数:30
被引数:3,436

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chronic HIV Infection Association with Cognition and ADRD Plasma Biomarkers in Uganda

慢性HIV感染与乌干达认知功能和ADRD血浆生物标志物的关联

2025-12-240
OAAI
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance

基于血液的阿尔茨海默病生物标志物在行为神经病学诊所的应用:真实世界实施、临床效用和诊断性能

2025-11-130
OAAI
Combining plasma neurofilament light chain and frontotemporal atrophy improves differentiation of bvFTD from primary psychiatric disorders

结合血浆神经丝蛋白轻链和额颞叶萎缩,可提高对bvFTD与原发性精神障碍的鉴别诊断能力。

2025-10-080
OAAI
Implementation of an Alzheimer’s Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study

阿尔茨海默病血液检测的实施:多中心研究中记忆照护专家的采用经验

2025-10-010
OAAI
Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum

血浆胶质纤维酸性蛋白在阿尔茨海默病连续谱中的调节作用

2025-09-050
OAAI
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline

路易体疾病与阿尔茨海默病及认知衰退关联中的性别差异

2025-07-110
OAAI
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

作者更正: 脑脊液蛋白质组的大规模网络分析确定了额颞叶变性的分子特征

2025-07-070
OAAI
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials

TabCAT-EXAMINER的开发与验证:一种基于平板电脑的用于研究和临床试验的执行功能测试组合

2025-03-010
PRE
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab( vol 146 , pg 777 , 2023)

共病病理可能影响靶向治疗淀粉样蛋白的治疗结局:来自接受阿杜单抗治疗的两位患者的临床病理结果(卷 146,页 777,2023)

2025-02-130
OA
Clinical and neuropathological associations of plasma Aβ42/Aβ40, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
2025-01-290
OA
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease

广泛实施基于血液的阿尔茨海默病生物标志物的考虑因素

2024-10-060
OA
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease

基于血液的阿尔茨海默病生物标志物的临床实施建议

2024-10-011
OAAI
CSF Proteomics in Patients With Progressive Supranuclear Palsy
2024-08-130
PRE
Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study

检查额颞叶痴呆的智能手机使用与临床严重程度之间的关联: 概念验证研究

2024-06-260
OAAI
An ANXA11 P93S variant dysregulates TDP-43 and causes corticobasal syndrome

ANXA11 P93S变体异常调节TDP-43并导致皮质基底综合征

2024-06-260
OA
Linking Type and Extent of Head Trauma to Cavum Septum Pellucidum in Older Adults With and Without Alzheimer Disease and Related Dementias
2024-04-091
OAAI